No results found for “”
No results found for filter “”
-
Statements & press releases 22.09.23
Orphan medicines: How the draft pharmaceutical legislation proposals would impact rare disease patients?...
As currently drafted, the European Commission proposals contained in the revised legislation would discourage the development of 45 rare disease treatments...
Read Article -
Blog articles 21.09.23
Rethinking Alzheimer's Disease: A Call to Action for Early Detection and Diagnosis
Charting a course to improve early detection and timely diagnosis of Alzheimer’s in Europe
Read Article -
Statements & press releases 13.09.23
SOTEU 2023: Reconciling policy and practice
Our hope now is that we can work with all parties to make the legislation enhance rather than hinder European competitiveness
Read Article -
Statements & press releases 12.09.23
Improving the understanding, acceptance and use of oncology–relevant endpoints in HTA body / payer decision-making...
How can we ensure that oncology-relevant endpoints reflect the value of innovation for patients, clinicians, payers and society?
Read Article -
Statements & press releases 12.09.23
EFPIA working with Ukraine on EU accession and medicines and vaccines regulatory alignment and patient...
Representatives from the European Federation of Pharmaceutical Industries and Associations (EFPIA) today met in Brussels with a high-level Ukrainian government...
Read Article -
Statements & press releases 06.09.23
EFPIA attends meeting to discuss opt-out requirements in EHDS
An opt-out or opt-in mechanism with regard to the secondary use of electronic health data may lead to health data disparities.
Read Article -
Blog articles 05.09.23
How the pharmaceutical industry is contributing to mitigate climate change
New industry survey highlights commitments and ambitions of 23 global pharmaceutical companies
Read Article -
Blog articles 01.08.23
Lung cancer: meeting patients’ needs through innovation
An inclusive definition of unmet medical need is vital to driving better outcomes for patients
Read Article -
Statements & press releases 27.07.23
EFPIA statement in response to the Commissions Communication on the European Citizen’s initiative on...
EFPIA members are committed to the science-based phase-in of methods to replace the use of animals for scientific purposes and the deletion of animal tests...
Read Article -
Blog articles 14.07.23
Are European policy makers losing interest in health?
What the European Semester 2023 tells us of the future of European health policy
Read Article -
EFPIA News 13.07.23
Joint Position Paper on the Hospital Exemption Scheme for ATMPs
Our organisations are committed to engage with policymakers and interested stakeholders for an inclusive and solutions-driven approach on the HE in the...
Read Article -
EFPIA News 13.07.23
Access to oncology combination therapies in Europe: Today's challenges and solutions
Despite the significant value combination therapies bring to cancer care, there are several challenges to their access in Europe. Without action, some...
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 13.07.23
Joint Position Paper on the Hospital Exemption Scheme for ATMPs
Our organisations are committed to engage with policymakers and interested stakeholders for an inclusive and solutions-driven approach on the HE in the...
Read Article -
EFPIA News 13.07.23
Access to oncology combination therapies in Europe: Today's challenges and solutions
Despite the significant value combination therapies bring to cancer care, there are several challenges to their access in Europe. Without action, some...
Read Article -
EFPIA News 12.06.23
IHI Calls 4 and 5: Publication of draft topics and opening of registration to call days
IHI Call Days: Calls 4 & 5
Read Article -
EFPIA News 27.04.23
IHI seeks patients and caregivers to contribute to its activities
IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen IHI’s ties with the patient community,...
Read Article -
EFPIA News 15.12.22
EFPIA survey among member companies on compliance with the EFPIA-PHRMA principles for responsible clinical...
EFPIA members continue to be committed to responsible clinical trial data sharing, for the benefit of patients and researchers
Read Article -
EFPIA News 13.12.22
IHI launches new funding round
The Innovative Health Initiative (IHI) has launched its third call for proposals, featuring topics covering rare diseases and mental health, and addressing...
Read Article -
EFPIA News 07.11.22
Europe’s share of global medicines R&D shrinks by a quarter in 20 years – as sector’s declining trends...
EFPIA is warning that the options being discussed by policy makers in the context of the EU Pharma Strategy fall well short of addressing concerns and...
Read Article -
EFPIA News 05.10.22
Pharmaceutical industry response to the war in Ukraine
Supporting people affected by the war
Read Article -
EFPIA News 16.06.22
European Multi-Stakeholder Sounding Board Meeting on “Innovation – The key to sustainable cancer care”...
Join the sounding board to discuss how high-quality care pathways and innovation can alleviate the pressure, improve sustainable patient access to high...
Read Article -
EFPIA News 24.05.22
RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!
Now is the time to rethink Alzheimer’s disease to improve Alzheimer’s disease care pathway and the lives of people living with it.
Read Article -
EFPIA News 02.05.22
Roberta Savli appointed as Executive Director of Public Affairs at EFPIA
Roberta will take on the new role with immediate effect.
Read Article -
EFPIA News 28.04.22
EFPIA Recommendations on a Connected Data System in Europe
A connected health data ecosystem has the potential to empower more effective and efficient research and development of new treatments and diagnostics....
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 22.09.23
Orphan medicines: How the draft pharmaceutical legislation proposals would impact rare disease patients?...
As currently drafted, the European Commission proposals contained in the revised legislation would discourage the development of 45 rare disease treatments...
Read Article -
Statements & press releases 13.09.23
SOTEU 2023: Reconciling policy and practice
Our hope now is that we can work with all parties to make the legislation enhance rather than hinder European competitiveness
Read Article -
Statements & press releases 12.09.23
Improving the understanding, acceptance and use of oncology–relevant endpoints in HTA body / payer decision-making...
How can we ensure that oncology-relevant endpoints reflect the value of innovation for patients, clinicians, payers and society?
Read Article -
Statements & press releases 12.09.23
EFPIA working with Ukraine on EU accession and medicines and vaccines regulatory alignment and patient...
Representatives from the European Federation of Pharmaceutical Industries and Associations (EFPIA) today met in Brussels with a high-level Ukrainian government...
Read Article -
Statements & press releases 06.09.23
EFPIA attends meeting to discuss opt-out requirements in EHDS
An opt-out or opt-in mechanism with regard to the secondary use of electronic health data may lead to health data disparities.
Read Article -
Statements & press releases 27.07.23
EFPIA statement in response to the Commissions Communication on the European Citizen’s initiative on...
EFPIA members are committed to the science-based phase-in of methods to replace the use of animals for scientific purposes and the deletion of animal tests...
Read Article -
Statements & press releases 12.07.23
EFPIA response to European Parliament position on EMA Fees Regulation
EFPIA welcomes the adoption of the EMA Fees regulation report by the European Parliament at the July Plenary session of MEP Busoi (EPP, Romania).
Read Article -
Statements & press releases 11.07.23
EFPIA statement on the EU-New Zealand FTA
We remain hopeful that the two sides will establish alternative platforms and dialogues where further discussions can take place to continue the work to...
Read Article -
Statements & press releases 07.07.23
Biopharma SMEs need clear incentives and stable legislation for Europe to remain competitive
A new survey published today by EFPIA details the financial environment that SMEs need to thrive in Europe and compete against regions like the US and...
Read Article -
Statements & press releases 04.07.23
NIRO: Navigating Innovation & Research Opportunities
A tool to help the private and public sector, not-for-profit organisations, and academia identify relevant R&I initiatives and programme opportunities
Read Article -
Statements & press releases 26.06.23
Precision approach to population health can benefit patients and health systems
New report highlights the potential of precision medicine and precision health to address common diseases across the care pathway.
Read Article -
Statements & press releases 22.06.23
Revise pharmaceutical legislation, or long-term access to medical breakthroughs for Europeans will be...
EFPIA, its member companies and the European Commission share the goals of increasing patient access to medicines across Europe and strengthening the competitiveness...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 21.09.23
Rethinking Alzheimer's Disease: A Call to Action for Early Detection and Diagnosis
Charting a course to improve early detection and timely diagnosis of Alzheimer’s in Europe
Read Article -
Blog articles 05.09.23
How the pharmaceutical industry is contributing to mitigate climate change
New industry survey highlights commitments and ambitions of 23 global pharmaceutical companies
Read Article -
Blog articles 01.08.23
Lung cancer: meeting patients’ needs through innovation
An inclusive definition of unmet medical need is vital to driving better outcomes for patients
Read Article -
Blog articles 14.07.23
Are European policy makers losing interest in health?
What the European Semester 2023 tells us of the future of European health policy
Read Article -
Blog articles 12.07.23
Unlocking the potential of precision oncology (Guest Blog)
The potential of precision oncology is there. To unleash it, we need to move forward together, working on ways to advance regulatory science, to screen...
Read Article -
Blog articles 12.07.23
Implementing cancer screening across the EU (Guest Blog)
The implementation of cancer screening programmes represents one of the policies that can make a meaningful improvement to health outcomes across Europe....
Read Article -
Blog articles 06.07.23
Prevention is the best medicine (Guest Blog)
Let’s all reflect on what each of us can do in the fight against cancer. And then let’s do it!
Read Article -
Blog articles 06.07.23
Innovation to safeguard sustainability of cancer care (Guest Blog)
Europe’s oncology workforce shortage will put patients at risk unless urgent action is taken to make cancer care more sustainable.
Read Article -
Blog articles 15.06.23
Industry disclosure of payments to health professionals and patients: Improving access to data (Guest...
EFPIA launches a new European gateway, an easy-to-navigate platform which connects all information disclosed by EFPIA companies and European countries
Read Article -
Blog articles 15.06.23
Shared decision making in kidney cancer: combining clinical evidence and patient preference to improve...
This year, we will continue to not only raise awareness of the importance of shared decision making in kidney cancer, but also to help make this a reality...
Read Article -
Blog articles 14.06.23
The patient expert who lived with an antimicrobial resistant infection for 15 years before he knew about...
Experience of living with Cystic Fibrosis (CF) and the impact AMR on one's health journey and the wider CF patient community
Read Article -
Blog articles 12.06.23
How is your country treating your heart? (Guest blog)
A set of CVD data across 22 European countries to see how CVD trends have developed over time, the existing disparities between countries and what key...
Read Article